- •Table of Contents
- •Copyright
- •Contributors
- •How to Use this Study Guide
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •4: Outcomes Research
- •Questions
- •Answers
- •5: Core Principles of Perioperative Care
- •Questions
- •Answers
- •Questions
- •Answers
- •7: Principles of Urologic Endoscopy
- •Questions
- •Answers
- •8: Percutaneous Approaches to the Upper Urinary Tract Collecting System
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •12: Infections of the Urinary Tract
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •15: Sexually Transmitted Diseases
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •20: Principles of Tissue Engineering
- •Questions
- •Answers
- •Questions
- •Answers
- •22: Male Reproductive Physiology
- •Questions
- •Answers
- •Questions
- •Answers
- •24: Male Infertility
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •28: Priapism
- •Questions
- •Answers
- •Questions
- •Answers
- •30: Surgery for Erectile Dysfunction
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •34: Neoplasms of the Testis
- •Questions
- •Answers
- •35: Surgery of Testicular Tumors
- •Questions
- •Answers
- •36: Laparoscopic and Robotic-Assisted Retroperitoneal Lymphadenectomy for Testicular Tumors
- •Questions
- •Answers
- •37: Tumors of the Penis
- •Questions
- •Answers
- •38: Tumors of the Urethra
- •Questions
- •Answers
- •39: Inguinal Node Dissection
- •Questions
- •Answers
- •40: Surgery of the Penis and Urethra
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •47: Renal Transplantation
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •50: Upper Urinary Tract Trauma
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •53: Strategies for Nonmedical Management of Upper Urinary Tract Calculi
- •Questions
- •Answers
- •54: Surgical Management for Upper Urinary Tract Calculi
- •Questions
- •Answers
- •55: Lower Urinary Tract Calculi
- •Questions
- •Answers
- •56: Benign Renal Tumors
- •Questions
- •Answers
- •57: Malignant Renal Tumors
- •Questions
- •Answers
- •Questions
- •Answers
- •59: Retroperitoneal Tumors
- •Questions
- •Answers
- •60: Open Surgery of the Kidney
- •Questions
- •Answers
- •Questions
- •Answers
- •62: Nonsurgical Focal Therapy for Renal Tumors
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •66: Surgery of the Adrenal Glands
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •71: Evaluation and Management of Women with Urinary Incontinence and Pelvic Prolapse
- •Questions
- •Answers
- •72: Evaluation and Management of Men with Urinary Incontinence
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •76: Overactive Bladder
- •Questions
- •Answers
- •77: Underactive Detrusor
- •Questions
- •Answers
- •78: Nocturia
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •82: Retropubic Suspension Surgery for Incontinence in Women
- •Questions
- •Answers
- •83: Vaginal and Abdominal Reconstructive Surgery for Pelvic Organ Prolapse
- •Questions
- •Answers
- •Questions
- •Answers
- •85: Complications Related to the Use of Mesh and Their Repair
- •Questions
- •Answers
- •86: Injection Therapy for Urinary Incontinence
- •Questions
- •Answers
- •87: Additional Therapies for Storage and Emptying Failure
- •Questions
- •Answers
- •88: Aging and Geriatric Urology
- •Questions
- •Answers
- •89: Urinary Tract Fistulae
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •92: Tumors of the Bladder
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •95: Transurethral and Open Surgery for Bladder Cancer
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •99: Orthotopic Urinary Diversion
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Answers
- •Questions
- •Answers
- •108: Prostate Cancer Tumor Markers
- •Questions
- •Answers
- •Questions
- •110: Pathology of Prostatic Neoplasia
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •114: Open Radical Prostatectomy
- •Questions
- •Answers
- •Questions
- •Answers
- •116: Radiation Therapy for Prostate Cancer
- •Questions
- •Answers
- •117: Focal Therapy for Prostate Cancer
- •Questions
- •Answers
- •Questions
- •Answers
- •119: Management of Biomedical Recurrence Following Definitive Therapy for Prostate Cancer
- •Questions
- •Answers
- •120: Hormone Therapy for Prostate Cancer
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •124: Perinatal Urology
- •Questions
- •Answers
- •Questions
- •Answers
- •126: Pediatric Urogenital Imaging
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •133: Surgery of the Ureter in Children
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •137: Vesicoureteral Reflux
- •Questions
- •Answers
- •138: Bladder Anomalies in Children
- •Questions
- •Answers
- •139: Exstrophy-Epispadias Complex
- •Questions
- •Answers
- •140: Prune-Belly Syndrome
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •144: Management of Defecation Disorders
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •147: Hypospadias
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •152: Adolescent and Transitional Urology
- •Questions
- •Answers
- •Questions
- •Answers
- •154: Pediatric Genitourinary Trauma
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
155
Pediatric Urologic Oncology
Renal and Adrenal
Michael L. Ritchey; Robert C. Shamberger
Questions
1.A chromosomal abnormality associated with an adverse prognosis in neuroblastoma is:
a.mutation of chromosome 11p15.
b.absence of the MDR gene.
c.mutation of the TP53 gene.
d.deletion of the short arm of chromosome 1.
e.loss of heterozygosity (LOH) for chromosome 11p13.
2.In situ neuroblastoma:
a.invariably progresses to clinical neuroblastoma.
b.usually regresses spontaneously.
c.is associated with deletion of chromosome 11.
d.is usually detected on newborn screening.
e.is frequently associated with amplification of the N-MYC oncogene.
3.Ganglioneuroma is:
a.a stroma-rich tumor by the Shimada classification.
b.most commonly located in the adrenal gland.
c.often found secondary to symptoms from metastatic disease.
d.associated with acute myoclonic encephalopathy.
e.associated with an unfavorable prognosis.
4.Screening for neuroblastoma:
a.has improved survival in patients with neuroblastoma.
b.has decreased the number of children older than 1 year with advanced
staged disease.
c.has identified more tumors with amplified N-MYC oncogene expression.
d.discovers tumors with an improved prognosis.
e.is widely performed in the United States.
5.A clinical feature associated with a favorable prognosis in neuroblastoma is:
a.age older than 2 years.
b.thoracic location of the primary tumor.
c.N-MYC amplification.
d.chromosome 1p deletion.
e.stroma-poor histology.
6.A 1-month-old girl is found to have a right suprarenal mass on abdominal ultrasound. The mass measures 4 cm in diameter. Imaging evaluation detects liver metastases. A skeletal survey is normal. Physical examination reveals multiple subcutaneous skin nodules. The mass is removed and confirmed to be neuroblastoma. Analysis of the tumor reveals no N-MYC amplification. The best next step is:
a.observation.
b.irradiation to the tumor bed.
c.vincristine, cyclophosphamide, and doxorubicin.
d.vincristine, cyclophosphamide, and irradiation to the tumor bed.
e.autologous bone marrow transplantation after chemotherapy and totalbody irradiation.
7.The Wilms tumor, Aniridia, Genital abnormalities, mental Retardation (WAGR) syndrome is most frequently associated with:
a.deletion of chromosome 15.
b.advanced-stage Wilms tumor.
c.neonatal presentation of Wilms tumor.
d.renal insufficiency.
e.familial predisposition to Wilms tumor.
8.A 3-year-old boy had undergone treatment for hypospadias and undescended testis as an infant. He develops renal insufficiency. Renal biopsy is consistent with a membranoproliferative glomerulonephritis. Appropriate management before renal transplantation is:
a.voiding cystourethrogram.
b.gonadal biopsy.
c.observation.
d.bilateral nephrectomy.
e.serial renal ultrasounds.
9.A 2-year-old boy has a palpable right-sided abdominal mass. Computed tomography (CT) shows this to be a solid lesion. On physical examination, the patient's right arm and leg are noted to be slightly longer in length. His diagnosis is most probably:
a.Wilms tumor.
b.neuroblastoma.
c.angiomyolipoma.
d.nephroblastomatosis.
e.renal call carcinoma.
.A newborn is identified with Beckwith-Wiedemann syndrome. A renal ultrasound is obtained. The clinical finding that best predicts the risk of subsequent Wilms tumor development is:
a.hepatomegaly.
b.hemihypertrophy.
c.nephromegaly.
d.mutation at chromosome 1p.
e.family history of Wilms tumor.
.A 6-month-old girl is diagnosed with aniridia. Ultrasounds are done every 3 months. This will result in:
a.increased survival.
b.detection of lower-stage renal tumor.
c.decreased incidence of bilateral tumors.
d.decreased surgical morbidity.
e.detection of tumors smaller than 3 cm in diameter.
.A deletion of chromosome 11 has been found most frequently in Wilms tumor patients with:
a.aniridia.
b.bilateral tumors.
c.hemihypertrophy.
d.Denys-Drash syndrome.
e.Beckwith-Wiedemann syndrome.
.A 5-year-old boy undergoes nephrectomy for a solid renal mass. Pathology reveals stage 1 favorable-histology Wilms tumor. An increased risk for tumor relapse is associated with:
a. tumor aneuploidy on flow cytometry.
b.deletion of chromosome 11p13.
c.duplication of chromosome 1.
d.LOH for chromosome 16q.
e.elevated serum ferritin level.
.A 2-year-old girl undergoes left nephrectomy for Wilms tumor. A solitary left pulmonary lesion is noted on chest CT. The pathology shows favorable histology but with capsular penetration. The most important prognostic feature is:
a.capsular penetration.
b.histologic subtype.
c.absence of lymph node involvement.
d.age at presentation.
e.presence of pulmonary metastasis.
.The feature associated with the worse survival in children with Wilms tumor is:
a.diffuse anaplasia.
b.diffuse tumor spill.
c.incomplete tumor resection.
d.tumor spread to periaortic lymph nodes.
e.lung metastasis.
.An increased risk for metachronous Wilms tumor is associated with:
a.anaplastic histology.
b.clear cell sarcoma.
c.blastemal predominant pattern.
d.renal sinus invasion.
e.nephrogenic rests.
.A 1-year-old boy undergoes nephrectomy for Wilms tumor. The finding that has the most adverse impact on survival is:
a.hilar lymph node involvement.
b.renal sinus invasion.
c.capsular penetration.
d.ureteral extension of tumor.
e.renal vein thrombus.
.The factor associated with the lowest risk of local tumor relapse in children with Wilms tumor is:
a.local tumor spill.
b.unfavorable histology.
c.incomplete tumor removal.
d.absence of lymph node sampling.
e.capsular penetration.
.A 4-year-old girl undergoes removal of a Wilms tumor of favorable histology. Imaging evaluation reveals multiple pulmonary metastases. Treatment should include vincristine, dactinomycin, and:
a.observation.
b.resection of the pulmonary lesions.
c.doxorubicin and chest irradiation.
d.doxorubicin, cyclophosphamide, and irradiation.
e.doxorubicin and etoposide.
.A 3-month-old boy undergoes removal of a 300-g Wilms tumor of the right kidney. The pathology shows diffuse anaplasia and tumor confined to the kidney. Lymph nodes were negative. The next step is:
a.observation.
b.vincristine and dactinomycin.
c.vincristine, dactinomycin, and irradiation of the tumor bed.
d.doxorubicin, vincristine, dactinomycin, and irradiation of the tumor bed.
e.ifosfamide, etoposide, and doxorubicin.
.A 5-year-old girl presents with hematuria. CT reveals a right abdominal mass with extension of tumor thrombus into the suprahepatic vena cava. The best next step is:
a.chemotherapy.
b.irradiation.
c.open biopsy followed by chemotherapy.
d.preoperative chemotherapy and radiation therapy.
e.primary surgical removal of the kidney and tumor thrombus.
.A 2-year-old boy is found to have bilateral Wilms tumor. There is a tumor occupying more than 50% of the left kidney and a 4.0-cm tumor in the upper pole of the right kidney. The best next step is:
a.left nephrectomy and right renal biopsy.
b.bilateral partial nephrectomy.
c.right partial nephrectomy and left renal biopsy.
d.bilateral nephrectomies.
e.chemotherapy.
. A 1-year-old girl has a stage III Wilms tumor. During the course of
chemotherapy she develops an enlarged heart and evidence of congestive heart failure. The drug responsible for these findings is most likely:
a.dactinomycin.
b.etoposide.
c.vincristine.
d.cyclophosphamide.
e.doxorubicin.
.A 1-year-old boy undergoes left radical nephrectomy for a large renal mass. The pathologic features associated with the worst prognosis are:
a.diffuse anaplasia stage I.
b.focal anaplasia stage III.
c.rhabdoid tumor of the kidney stage III.
d.clear cell sarcoma of the kidney stage III.
e.favorable histology stage IV.
.A newborn boy was noted to have a left renal mass on prenatal ultrasound. Postnatal evaluation confirms a 5-cm solid mass in the lower pole of the left kidney. The right kidney is normal. Chest radiography and CT of the chest are negative for metastatic disease. The mass was completely removed by a radical nephrectomy. The tumor was confined to the kidney and weighed 300 g. The next step in treatment is:
a.1200-cGy abdominal irradiation to the left flank.
b.observation only.
c.dactinomycin and vincristine for 10 weeks.
d.dactinomycin and vincristine for 18 weeks.
e.2000-cGy abdominal irradiation plus dactinomycin and vincristine for 18 weeks.
.The tuberous sclerosis complex is associated with the development of angiomyolipoma and cystic renal disease. These patients have been found to have an abnormality of chromosome:
a.1.
b.7.
c.9.
d.12.
e.14.
Pathology
1.A 4-year-old boy had a right radical nephrectomy for a renal mass. The histology is depicted in Figure 155-1 and is reported as a Wilms tumor with negative margins. Additional information from the pathologist should include a statement as to:
FIGURE 155–1 (From Bostwick DG, Cheng L. Urologic surgical pathology. 3rd ed. St. Louis: Elsevier; 2014.)
a.differentiation of the blastema.
b.differentiation of the stroma.
c.differentiation of the epithelial component.
d.the presence of an anaplastic variant.
e.the presence of clear cell cancer.
2.A 3-month-old male infant is noted to have a large solid right renal mass. A nephrectomy is performed. The histology is depicted in Figure 155-2 and is reported as a spindle cell tumor. The pathologist should be queried as to: